Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

Similar articles for PubMed (Select 20689826)

1.

Nuclear S100A7 is associated with poor prognosis in head and neck cancer.

Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Siu KW.

PLoS One. 2010 Aug 3;5(8):e11939. doi: 10.1371/journal.pone.0011939.

2.

Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.

Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, Dattagupta S, Sharma MC, Ralhan R, Siu KW.

PLoS One. 2011 May 5;6(5):e19213. doi: 10.1371/journal.pone.0019213.

3.

Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma.

Matta A, Tripathi SC, DeSouza LV, Grigull J, Kaur J, Chauhan SS, Srivastava A, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Michael Siu KW.

Int J Cancer. 2009 Sep 15;125(6):1398-406. doi: 10.1002/ijc.24517.

PMID:
19548310
4.

S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.

Kaur J, Matta A, Kak I, Srivastava G, Assi J, Leong I, Witterick I, Colgan TJ, Macmillan C, Siu KW, Walfish PG, Ralhan R.

Int J Cancer. 2014 Mar 15;134(6):1379-88. doi: 10.1002/ijc.28473. Epub 2013 Oct 8.

PMID:
24122701
5.

Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.

Matta A, DeSouza LV, Shukla NK, Gupta SD, Ralhan R, Siu KW.

J Proteome Res. 2008 May;7(5):2078-87. doi: 10.1021/pr7007797. Epub 2008 Apr 12.

PMID:
18407684
6.

Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma.

Li X, Nishida T, Noguchi A, Zheng Y, Takahashi H, Yang X, Masuda S, Takano Y.

J Cancer Res Clin Oncol. 2010 Oct;136(10):1573-83. doi: 10.1007/s00432-010-0815-x. Epub 2010 Feb 25.

PMID:
20182888
7.

Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.

Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.

J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.

PMID:
20593490
8.

Clinical significance of TC21 overexpression in oral cancer.

Macha MA, Matta A, Sriram U, Thakkar A, Shukla NK, Datta Gupta S, Ralhan R.

J Oral Pathol Med. 2010 Jul;39(6):477-85. doi: 10.1111/j.1600-0714.2009.00854.x. Epub 2009 Dec 16.

PMID:
20040018
9.

Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.

Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD, Gutkind JS.

Clin Cancer Res. 2008 Feb 15;14(4):1002-14. doi: 10.1158/1078-0432.CCR-07-1497.

10.

Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.

Bongers V, Snow GB, de Vries N, Cattan AR, Hall AG, van der Waal I, Braakhuis BJ.

Lab Invest. 1995 Oct;73(4):503-10.

PMID:
7474922
11.

Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.

Tripathi SC, Kaur J, Matta A, Gao X, Sun B, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, DattaGupta S, Sharma MC, Ralhan R, Siu KW.

Mod Pathol. 2012 Jan;25(1):14-25. doi: 10.1038/modpathol.2011.145. Epub 2011 Oct 14.

12.

Cytoplasmic expression of p33ING1b is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.

Li XH, Noguchi A, Nishida T, Takahashi H, Zheng Y, Yang XH, Masuda S, Kikuchi K, Takano Y.

Histol Histopathol. 2011 May;26(5):597-607.

PMID:
21432775
13.

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Pavelić K, Krizanac S, Cacev T, Hadzija MP, Radosević S, Crnić I, Levanat S, Kapitanović S.

Mol Med. 2001 Jul;7(7):442-53.

14.

Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.

de Koning PJ, Bovenschen N, Leusink FK, Broekhuizen R, Quadir R, van Gemert JT, Hordijk GJ, Chang WS, van der Tweel I, Tilanus MG, Kummer JA.

Int J Cancer. 2009 Oct 1;125(7):1542-50. doi: 10.1002/ijc.24507.

PMID:
19569240
15.

Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.

Wood MW, Medina JE, Thompson GC, Houck JR, Min KW.

Otolaryngol Head Neck Surg. 1994 Dec;111(6):758-63.

PMID:
7527509
16.

Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients.

Sawhney M, Matta A, Macha MA, Kaur J, DattaGupta S, Shukla NK, Ralhan R.

Int J Cancer. 2009 May 1;124(9):2098-105. doi: 10.1002/ijc.24192.

PMID:
19142865
17.

Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma.

Lee CC, Ho HC, Lee MS, Hung SK, Yu CC, Su YC.

Clin Chim Acta. 2010 Aug 5;411(15-16):1116-21. doi: 10.1016/j.cca.2010.04.010. Epub 2010 Apr 22.

PMID:
20417195
18.

Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.

Michalides RJ, van Veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ, Balm AJ.

Arch Otolaryngol Head Neck Surg. 1997 May;123(5):497-502.

PMID:
9158396
19.

Stromelysin-3 expression is an early event in human oral tumorigenesis.

Soni S, Mathur M, Shukla NK, Deo SV, Ralhan R.

Int J Cancer. 2003 Nov 1;107(2):309-16.

PMID:
12949813
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk